Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

SF3B1 Mutations in Primary Myelofibrosis: Clinical, Histopathology and Genetic Correlates Among 155 Patients

Leukemia

English

European LeukemiaNet 2020 Recommendations for Treating Chronic Myeloid Leukemia

English

Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia

English

Inducible T-Cell Receptor Expression in Precursor T Cells for Leukemia Control

English

The Therapeutic Effectiveness of 177Lu-Lilotomab in B-Cell Non-Hodgkin Lymphoma Involves Modulation of G2/M Cell Cycle Arrest

English

Treatment of Relapsed or Refractory Classical Hodgkin Lymphoma With the Anti-Pd-1, Tislelizumab: Results of a Phase 2, Single-Arm, Multicenter Study

English

HDAC3 Regulates DNMT1 Expression in Multiple Myeloma: Therapeutic Implications

English

Retraction Note: Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

English

Transient Stabilization, Rather Than Inhibition, of MYC Amplifies Extrinsic Apoptosis and Therapeutic Responses in Refractory B-Cell Lymphoma

English

Nucleoside Analog ARC Targets McL-1 to Induce Apoptosis in Leukemia Cells

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

SF3B1 Mutations in Primary Myelofibrosis: Clinical, Histopathology and Genetic Correlates Among 155 Patients

European LeukemiaNet 2020 Recommendations for Treating Chronic Myeloid Leukemia

Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia

Inducible T-Cell Receptor Expression in Precursor T Cells for Leukemia Control

The Therapeutic Effectiveness of 177Lu-Lilotomab in B-Cell Non-Hodgkin Lymphoma Involves Modulation of G2/M Cell Cycle Arrest

Treatment of Relapsed or Refractory Classical Hodgkin Lymphoma With the Anti-Pd-1, Tislelizumab: Results of a Phase 2, Single-Arm, Multicenter Study

HDAC3 Regulates DNMT1 Expression in Multiple Myeloma: Therapeutic Implications

Retraction Note: Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

Transient Stabilization, Rather Than Inhibition, of MYC Amplifies Extrinsic Apoptosis and Therapeutic Responses in Refractory B-Cell Lymphoma

Nucleoside Analog ARC Targets McL-1 to Induce Apoptosis in Leukemia Cells